Evaluation of New Hyaluronic Acid Fillers

Standard for Non-Surgical Correction

Hyaluronic Acid (HA) fillers are widely regarded as the gold standard for non-surgical correction of nasolabial folds and crow’s feet. However, clinicians continually seek improved options to enhance patient experiences and outcomes.

Current Popularity of HA Fillers

Hyaluronic acid is the most commonly used facial filler for addressing significant signs of aging, particularly deep nasolabial folds and wrinkles around the eyes. Viscos HA is injected into the dermis to fill in these furrows and maintain facial shape. Its unique composition minimizes adverse reactions and side effects, making HA a safe choice for non-surgical facial rejuvenation.

Addressing Pain During Procedures

Despite its popularity, HA fillers are not without drawbacks; subdermal injections can be painful for patients. In response to this issue, newer formulations have been developed that combine HA with lidocaine, an anesthetic, to enhance comfort during treatment.

Study on New HA Fillers Infused with Lidocaine

Research Methodology

To assess the potential of these new fillers, dermatologists conducted a rigorous study comparing their effects to those of existing HA fillers. The study involved over 70 patients across multiple centers in Europe. Participants received filler injections to treat either nasolabial folds, crow’s feet, or both, and were monitored for efficacy and tolerability.

Blinded Comparison of Fillers

A split-face method was employed for the comparison; one side of the patient’s face was treated with a standard HA filler, while the other side received the new experimental formulation. Both the patients and treating physicians were unaware of which filler was applied to each side, effectively eliminating bias.

Results and Follow-Up

Patients were evaluated 30 and 45 days post-treatment. Objective assessments revealed that the results from both established and newer formulations were comparable in terms of efficacy—how well symptoms were alleviated—and tolerability, with no significant adverse effects reported.

Future Implications of New Formulations

Encouraging Findings and Further Research

The encouraging results from the study have prompted further exploration, with additional studies planned to assess outcomes at 90 and 180 days after treatment. If these newer formulations demonstrate equivalent efficacy, they may eventually replace current products in the market.

Enhancing Patient Experience

In addition to improving the appearance of aging, these innovative fillers offer the potential for a significantly less painful treatment experience.

Author Information

Written By: Jay Martin, M.D.